SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (26833)12/9/1998 5:34:00 PM
From: aknahow  Read Replies (3) | Respond to of 32384
 
Henry, just felt it was time to say thanks. I appreciate the results of your efforts to bring together a lot of information in a very convenient form. The performance, good or poor, of LGND or any other stock you might mention has nothing to do with having to recognize you for doing a really neat job.

You certainly have organized the merger news, and I find it very useful.



To: Henry Niman who wrote (26833)12/9/1998 6:13:00 PM
From: Cheryl Galt  Respond to of 32384
 
ASH brought positive publicity to the sector. This weekend we'll get more from an Informed Investors Forum focused on companies doing cancer research.
--------------------------------------------------------------

Biotechs Battling Cancer — Second Annual Seattle BioScience Stocks Forum Dec. 12

"The vaccine approach, and several others in the biotech industry's war on cancer,
will be the primary theme of executive corporate presentations to individual investors ... "

Keynote address: "New Genetic Approaches To Drug Discovery"
by Lee Hartwell, Director of the Fred Hutchinson Cancer Research Center.

800/992-4683 to register or order tapes. informedinvestors.com
The Forum is co-sponsored by BioSpace.com --- biospace.com
-------------------------------------------------------------

It will be nice if any price pop that we get from this sector publicity *sticks* for a while.

I hope that the forum promotes confidence in the sector (not unrealistic hype for some individual stock -- which I believe hurts the sector).

More than that, I hope that publicity about current research stimulates investment and grants for those doing such research.

Cheryl